Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

ARS Pharmaceuticals Officer Karas Files to Sell 139,588 Shares

ARS Pharmaceuticals, Inc. officer Eric Karas filed a Form 144 notice of proposed sale on November 9, 2026, disclosing plans to sell 139,588 shares of common stock acquired through a stock option exercise on the same date.

Manish Choudhary | 09 November 2026

Hippo Holdings Officer McCathron Plans 5,000-Share Sale

Richard McCathron, an officer of Hippo Holdings Inc., filed a Form 144 notice of proposed sale of 5,000 shares of common stock, with an approximate sale date of November 9, 2026, through Merrill Lynch in San Francisco.

Anjali Anand | 09 November 2026

Uri Rubin Plans to Sell 220,000 Playtika Shares

Playtika Holding Corp. officer Uri Rubin filed a Form 144 notice of proposed sale of 220,000 common shares, submitted on November 9, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.

Vinay Lochav | 09 November 2026

Dirk Allison Plans Sale of 98,958 Addus HomeCare Shares

Addus HomeCare Corporation officer and director Dirk Allison filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 98,958 shares of common stock acquired through a stock option exercise.

Aditi Sarkar | 09 November 2026

Bio-Rad Officer James Barry Plans to Sell 1,400 Shares

Bio-Rad Laboratories, Inc. officer James Barry filed a Form 144 notice of proposed sale of 1,400 shares of Bio-Rad common stock, submitted on November 9, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.

Shwetambri Chauhan | 09 November 2026

Sumit Sadana Plans to Sell 5,000 Micron Shares in November 2026

Micron Technology, Inc. officer Sumit Sadana filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 5,000 shares of Micron common stock with an approximate sale date of November 9, 2026.

Aditi Sarkar | 09 November 2026

Bio-Rad Officer DiVincenzo Plans to Sell 919 Common Shares

Jonathan DiVincenzo, an officer of Bio-Rad Laboratories, Inc., filed a Form 144 notice of proposed sale of securities with the SEC on November 9, 2026, disclosing plans to sell 919 shares of Bio-Rad common stock on NYSE.

Anjali Anand | 09 November 2026

TransMedics Director James Tobin Plans Sale of 4,059 Shares

TransMedics Group, Inc. director James R. Tobin filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 4,059 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services.

Shwetambri Chauhan | 09 November 2026

Consensus Cloud Director Simmons Files to Sell 8,003 Shares

Director Nathaniel Simmons of Consensus Cloud Solutions, Inc. filed a Form 144 notice of proposed sale of 8,003 shares of common stock, with an approximate sale date of November 9, 2026, executed through Morgan Stanley Smith Barney LLC.

Vinay Lochav | 09 November 2026

Replimune Director Slattery Plans Sale of 5,200 Shares

Director Joseph P. Slattery filed a Form 144 notice with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing a proposed sale of 5,200 shares of Replimune Group, Inc. common stock through Morgan Stanley Smith Barney LLC.

Manish Choudhary | 09 November 2026
Support

Hi! How can we help you today?

Loading…